Related Experiment Video
Updated: Jul 7, 2026

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Correlation between late gadolinium enhancement and diastolic function in hypertrophic cardiomyopathy assessed by
Munenobu Motoyasu1, Tairo Kurita, Katsuya Onishi
1Department of Cardiology, Mie University Graduate School of Medicine, Tsu, Japan.
Insights
The extent of myocardial fibrosis in hypertrophic cardiomyopathy (HCM) patients, measured by late gadolinium-enhanced MRI, strongly correlates with diastolic dysfunction. This finding highlights the link between fibrosis and impaired heart function in HCM.
Area of Science:
- Cardiovascular Imaging
- Cardiac MRI
- Cardiomyopathy Research
Background:
- Diastolic dysfunction is a prevalent issue in patients diagnosed with overt hypertrophic cardiomyopathy (HCM).
- Steady-state cine magnetic resonance imaging (MRI) is a key tool for assessing left ventricular (LV) diastolic function.
- Late gadolinium-enhanced MRI (LGE-MRI) effectively visualizes myocardial fibrosis in HCM patients.
Purpose of the Study:
- To investigate the relationship between the extent of myocardial fibrosis, as detected by LGE-MRI, and the presence of diastolic dysfunction in HCM patients.
Main Methods:
- Seventeen HCM patients underwent LGE-MRI to quantify myocardial fibrosis severity and cine MRI to assess LV diastolic function parameters, including peak filling rate (PFR) and LV ejection fraction.
- Fibrosis extent was evaluated using a severity index based on scoring enhanced tissue across 30 myocardial segments.
- Correlation analyses were performed between the LGE severity index and diastolic function metrics.
Main Results:
- LGE-MRI revealed myocardial fibrosis in 77% of patients (13 out of 17), affecting 19% of myocardial segments analyzed.
- A significant negative correlation was found between the LGE severity index and both PFR (r = -0.86, p<0.01) and LV ejection fraction (r = -0.59, p<0.05).
- No significant correlation was observed between fibrosis extent and LV mass (r = 0.23, p=0.30).
Conclusions:
- The degree of myocardial fibrosis, as quantified by LGE-MRI, is strongly associated with diastolic dysfunction in patients with hypertrophic cardiomyopathy.
- LGE-MRI is a valuable tool for understanding the pathophysiological mechanisms underlying diastolic dysfunction in HCM.
Background:
Diastolic dysfunction is common in patients with overt hypertrophic cardiomyopathy (HCM). Steady-state cine magnetic resonance imaging (MRI) enables measurement of the diastolic function of the left ventricle (LV), and late gadolinium enhanced MRI can delineate the presence and extent of fibrosis in HCM. The purpose of this study was to determine the relationship between the extent of myocardial fibrosis demonstrated by late gadolinium-enhanced MRI and diastolic dysfunction.
Methods And Results:
Seventeen patients (13 men, mean age 57.7+/-9.8 years) with HCM were studied. The severity index of late gadolinium enhancement was determined by scoring the extent of enhanced tissue in 30 myocardial segments. The peak filling rate (PFR), LV ejection fraction and LV mass were determined by cine MRI. Contrast-enhanced MRI demonstrated late gadolinium enhancement in 97 of 510 segments (19%) and 13 of the 17 patients (77%). The severity index of late gadolinium enhancement demonstrated a significant negative correlation with PFR (r= -0.86, p<0.01) and with the LV ejection fraction (r= -0.59, p<0.05). No significant correlation was observed between the severity index of late gadolinium enhancement and LV mass (r=0.23, p=0.30).
Conclusion:
The extent of myocardial fibrosis revealed by late gadolinium-enhanced MRI has a strong relationship to diastolic dysfunction in patients with HCM.
More Related Videos
08:57Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease
Published on: May 22, 2026
11:13Quantification of Mouse Heart Left Ventricular Function, Myocardial Strain, and Hemodynamic Forces by Cardiovascular Magnetic Resonance Imaging
Published on: May 24, 2021
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure II: Pathophysiology
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Cardiomyopathy IV: Restrictive Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests